In conclusion, our studies show that the BET inhibitor JQ1 can reduce proliferation and increase apoptosis of NET cells in vitro and pancreatic NETs in vivo, thereby indicating the potential utility of BET inhibitors in the treatment of NETs. The gene discussed is DNER; the disease is pancreatic neuroendocrine tumor.